Interactions between the intestinal microbiota and innate lymphoid cells

Gut Microbes

Volumn 5, Issue 1, 2013, Pages

  Chen, Vincent L ^a   Kasper, Dennis L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Innate lymphoid cell; Intestinal immunity; Lymphoid tissue inducer cell; Microbiota; Polysaccharide A

Indexed keywords

ANIMAL; BACTERIUM; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE; LYMPHOCYTE; MICROBIOLOGY; MICROFLORA;

ANIMALS; BACTERIA; HUMANS; IMMUNITY, INNATE; INTESTINES; LYMPHOCYTES; MICROBIOTA;

EID: 84892578020     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.27289     Document Type: Review

References (183)

1. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307:1915-20; PMID:15790844; http://dx.doi.org/10.1126/ science.1104816
2. Chung H, Kasper DL. Microbiota-stimulated immune mechanisms to maintain gut homeostasis. Curr Opin Immunol 2010; 22:455-60; PMID:20656465; http://dx.doi.org/10.1016/j. coi.2010.06.008
3. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312:1355-9; PMID:16741115; http://dx.doi.org/10.1126/ science.1124234
4. Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 2005; 3:431-8; PMID:15821725; http://dx.doi. org/10.1038/nrmicro1152
5. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 2002; 99:15451-5; PMID:12432102; http://dx.doi.org/10.1073/pnas.202604299
6. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 2011; 108:3047-52; PMID:21282636; http://dx.doi. org/10.1073/pnas.1010529108
7. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al.; MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65; PMID:20203603; http://dx.doi.org/10.1038/ nature08821
8. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O'Sullivan O, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012; 488:178-84; PMID:22797518; http://dx.doi.org/10.1038/ nature11319
9. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004; 101:15718-23; PMID:15505215; http://dx.doi.org/10.1073/ pnas.0407076101
10. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005; 102:11070-5; PMID:16033867; http://dx.doi.org/10.1073/ pnas.0504978102
11. Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 2011; 62:361-80; PMID:21226616; http://dx.doi. org/10.1146/annurev-med-012510-175505
12. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027-31; PMID:17183312; http://dx.doi.org/10.1038/nature05414
13. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328:228-31; PMID:20203013; http://dx.doi.org/10.1126/science.1179721
14. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, Parameswaran P, Crowell MD, Wing R, Rittmann BE, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 2009; 106:2365-70; PMID:19164560; http:// dx.doi.org/10.1073/pnas.0812600106
15. Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 1995; 61:3202-7; PMID:7574628
16. Marchesi JR, Dutilh BE, Hall N, Peters WHM, Roelofs R, Boleij A, Tjalsma H. Towards the human colorectal cancer microbiome. PLoS One 2011; 6:e20447; PMID:21647227; http://dx.doi. org/10.1371/journal.pone.0020447
17. Pflughoeft KJ, Versalovic J. Human microbiome in health and disease. Annu Rev Pathol 2012; 7:99-122; PMID:21910623; http://dx.doi.org/10.1146/ annurev-pathol-011811-132421
18. Azad MB, Kozyrskyj AL. Perinatal programming of asthma: the role of gut microbiota. Clin Dev Immunol 2012; 2012:932072; PMID:22110540; http://dx.doi.org/10.1155/2012/932072
19. Huffnagle GB. The microbiota and allergies/asthma. PLoS Pathog 2010; 6:e1000549; PMID:20523892; http://dx.doi.org/10.1371/journal.ppat.1000549
20. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser A-L, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF. High prevalence of adherent-invasive associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127:412-21; PMID:15300573; http://dx.doi.org/10.1053/j. gastro.2004.04.061
21. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, et al. Is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105:16731-6; PMID:18936492; http://dx.doi.org/10.1073/ pnas.0804812105
22. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472:57-63; PMID:21475195; http://dx.doi. org/10.1038/nature09922
23. Tang WHW, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368:1575-84; PMID:23614584; http://dx.doi.org/10.1056/ NEJMoa1109400
24. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, Reading NC, Villablanca EJ, Wang S, Mora JR, et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 2012; 149:1578-93; PMID:22726443; http://dx.doi. org/10.1016/j.cell.2012.04.037
25. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, et al. Induction of colonic regulatory T cells by indigenous species. Science 2011; 331:337-41; PMID:21205640; http://dx.doi.org/10.1126/ science.1198469
26. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139:485-98; PMID:19836068; http://dx.doi.org/10.1016/j. cell.2009.09.033
27. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122:107-18; PMID:16009137; http:// dx.doi.org/10.1016/j.cell.2005.05.007
28. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453:620-5; PMID:18509436; http://dx.doi.org/10.1038/nature07008
29. Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De Paepe M, Brandi G, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009; 31:677-89; PMID:19833089; http://dx.doi.org/10.1016/j. immuni.2009.08.020
30. Talham GL, Jiang H-Q, Bos NA, Cebra JJ. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect Immun 1999; 67:1992-2000; PMID:10085047
31. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9:313-23; PMID:19343057; http://dx.doi.org/10.1038/nri2515
32. Duan J, Kasper DL. Regulation of T cells by gut commensal microbiota. Curr Opin Rheumatol 2011; 23:372-6; PMID:21577116; http://dx.doi. org/10.1097/BOR.0b013e3283476d3e
33. Dasgupta S, Kasper DL. Novel tools for modulating immune responses in the host-polysaccharides from the capsule of commensal bacteria. Adv Immunol 2010; 106:61-91; PMID:20728024; http://dx.doi. org/10.1016/S0065-2776(10)06003-7
34. Eberl G. Inducible lymphoid tissues in the adult gut: recapitulation of a fetal developmental pathway? Nat Rev Immunol 2005; 5:413-20; PMID:15841100; http://dx.doi.org/10.1038/nri1600
35. Witmer MD, Steinman RM. The anatomy of peripheral lymphoid organs with emphasis on accessory cells: light-microscopic immunocytochemical studies of mouse spleen, lymph node, and Peyer's patch. Am J Anat 1984; 170:465-81; PMID:6475812; http:// dx.doi.org/10.1002/aja.1001700318
36. Makala LHC, Suzuki N, Nagasawa H. Peyer's patches: organized lymphoid structures for the induction of mucosal immune responses in the intestine. Pathobiology 2002-2003; 70:55-68; PMID:12476030; http://dx.doi. org/10.1159/000067305
37. Bockman DE, Cooper MD. Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix, and Peyer's patches. An electron microscopic study. Am J Anat 1973; 136:455-77; PMID:4692973; http://dx.doi.org/10.1002/ aja.1001360406
38. Owen RL, Pierce NF, Apple RT, Cray WC Jr. M cell transport of from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. J Infect Dis 1986; 153:1108-18; PMID:2422297; http://dx.doi. org/10.1093/infdis/153.6.1108
39. Pappo J, Ermak TH. Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake. Clin Exp Immunol 1989; 76:144-8; PMID:2661061
40. Kelsall BL, Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J Exp Med 1996; 183:237-47; PMID:8551227; http://dx.doi. org/10.1084/jem.183.1.237
41. Iwasaki A, Kelsall BL. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3α, MIP-3β, and secondary lymphoid organ chemokine. J Exp Med 2000; 191:1381-94; PMID:10770804; http://dx.doi.org/10.1084/ jem.191.8.1381
42. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004; 303:1662-5; PMID:15016999; http://dx.doi.org/10.1126/science.1091334
43. Pierce NF, Gowans JL. Cellular kinetics of the intestinal immune response to cholera toxoid in rats. J Exp Med 1975; 142:1550-63; PMID:1238506; http:// dx.doi.org/10.1084/jem.142.6.1550
44. Williams AF, Gowans JL. The presence of IgA on the surface of rat thoractic duct lymphocytes which contain internal IgA. J Exp Med 1975; 141:335-45; PMID:1089743; http://dx.doi.org/10.1084/ jem.141.2.335
45. Arstila T, Arstila TP, Calbo S, Selz F, Malassis-Seris M, Vassalli P, Kourilsky P, Guy-Grand D. Identical T cell clones are located within the mouse gut epithelium and lamina propia and circulate in the thoracic duct lymph. J Exp Med 2000; 191:823-34; PMID:10755885; http://dx.doi.org/10.1084/ jem.191.5.823
46. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004; 4:478-85; PMID:15173836; http://dx.doi.org/10.1038/nri1373
47. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10:159-69; PMID:20182457; http://dx.doi.org/10.1038/nri2710
48. Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol 2007; 25:381-418; PMID:17378762; http://dx.doi. org/10.1146/annurev.immunol.25.022106.141634
49. Johansson C, Kelsall BL. Phenotype and function of intestinal dendritic cells. Semin Immunol 2005; 17:284-94; PMID:15978836; http://dx.doi. org/10.1016/j.smim.2005.05.010
50. Niess JH, Reinecker H-C. Dendritic cells: the commanders-in-chief of mucosal immune defenses. Curr Opin Gastroenterol 2006; 22:354-60; PMID:16760749; http://dx.doi.org/10.1097/01. mog.0000231807.03149.54
51. Varol C, Vallon-Eberhard A, Elinav E, Aychek T, Shapira Y, Luche H, Fehling HJ, Hardt WD, Shakhar G, Jung S. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009; 31:502-12; PMID:19733097; http://dx.doi. org/10.1016/j.immuni.2009.06.025
52. Craig SW, Cebra JJ. Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J Exp Med 1971; 134:188-200; PMID:4934147; http://dx.doi.org/10.1084/ jem.134.1.188
53. Macpherson AJ, Slack E. The functional interactions of commensal bacteria with intestinal secretory IgA. Curr Opin Gastroenterol 2007; 23:673-8; PMID:17906446; http://dx.doi.org/10.1097/ MOG.0b013e3282f0d012
54. Bouskra D, Brézillon C, Bérard M, Werts C, Varona R, Boneca IG, Eberl G. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008; 456:507-10; PMID:18987631; http://dx.doi.org/10.1038/ nature07450
55. Kang H-S, Chin RK, Wang Y, Yu P, Wang J, Newell KA, Fu YX. Signaling via LTbetaR on the lamina propria stromal cells of the gut is required for IgA production. Nat Immunol 2002; 3:576-82; PMID:12006975; http://dx.doi.org/10.1038/ni795
56. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, et al. Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13:145-9; PMID:23348417; http://dx.doi. org/10.1038/nri3365
57. Veldhoen M, Withers DR. Immunology. Innate lymphoid cell relations. Science 2010; 330:594-5; PMID:21030634; http://dx.doi.org/10.1126/ science.1198298
58. Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 2012; 30:647-75; PMID:22224763; http://dx.doi.org/10.1146/ annurev-immunol-020711-075053
59. Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, Cella M, Colonna M. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12-and IL-15-responsive IFN-γ-producing cells. Immunity 2013; 38:769-81; PMID:23453631; http://dx.doi.org/10.1016/j.immuni.2013.02.010
60. H1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 2002; 295:338-42; PMID:11786644; http://dx.doi.org/10.1126/ science.1065543
61. Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, Hreggvidsdottir HS, Heinsbroek SE, Legrand N, Buskens CJ, et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 2013; 14:221-9; PMID:23334791; http://dx.doi.org/10.1038/ni.2534
62. Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F, Caligiuri MA. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 1999; 162:4511-20; PMID:10201989
63. Lauwerys BR, Garot N, Renauld J-C, Houssiau FA. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J Immunol 2000; 165:1847-53; PMID:10925263
64. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633-40; PMID:11698225; http://dx.doi.org/10.1016/S1471-4906(01)02060-9
65. Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev 2006; 214:56-72; PMID:17100876; http://dx.doi. org/10.1111/j.1600-065X.2006.00451.x
66. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004; 305:872-4; PMID:15297676; http:// dx.doi.org/10.1126/science.1097670
67. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, Yokoyama WM. Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2001; 2:951-6; PMID:11550009; http://dx.doi. org/10.1038/ni714
68. Borg C, Terme M, Taïeb J, Ménard C, Flament C, Robert C, Maruyama K, Wakasugi H, Angevin E, Thielemans K, et al. Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects. J Clin Invest 2004; 114:379-88; PMID:15286804
69. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295:2097-100; PMID:11896281; http://dx.doi.org/10.1126/ science.1068440
70. Deguine J, Breart B, Lemaître F, Bousso P. Cutting edge: tumor-targeting antibodies enhance NKG2Dmediated NK cell cytotoxicity by stabilizing NK celltumor cell interactions. J Immunol 2012; 189:5493-7; PMID:23183896; http://dx.doi.org/10.4049/ jimmunol.1202065
71. Baxter AG, Smyth MJ. The role of NK cells in autoimmune disease. Autoimmunity 2002; 35:1-14; PMID:11908701; http://dx.doi. org/10.1080/08916930290005864
72. Walzer T, Bléry M, Chaix J, Fuseri N, Chasson L, Robbins SH, Jaeger S, André P, Gauthier L, Daniel L, et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci U S A 2007; 104:3384-9; PMID:17360655; http://dx.doi.org/10.1073/pnas.0609692104
73. Halim TY, Krauss RH, Sun AC, Takei F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 2012; 36:451-63; PMID:22425247; http://dx.doi.org/10.1016/j.immuni.2011.12.020
74. +) lymphoid cells. Nature 2010; 463:540-4; PMID:20023630; http://dx.doi.org/10.1038/nature08636
75. Mjösberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011; 12:1055-62; PMID:21909091; http://dx.doi.org/10.1038/ni.2104
76. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TKA, Bucks C, Kane CM, Fallon PG, Pannell R, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464:1367-70; PMID:20200518; http://dx.doi.org/10.1038/nature08900
77. Klein Wolterink RG, Kleinjan A, van Nimwegen M, Bergen I, de Bruijn M, Levani Y, Hendriks RW. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol 2012; 42:1106-16; PMID:22539286; http://dx.doi.org/10.1002/eji.201142018
78. Chang Y-J, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, Dekruyff RH, Umetsu DT. Innate lymphoid cells mediate influenzainduced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011; 12:631-8; PMID:21623379; http://dx.doi.org/10.1038/ni.2045
79. Monticelli LA, Sonnenberg GF, Artis D. Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung. Curr Opin Immunol 2012; 24:284-9; PMID:22521139; http:// dx.doi.org/10.1016/j.coi.2012.03.012
80. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12:1045-54; PMID:21946417; http://dx.doi.org/10.1038/ ni.2131
81. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010; 464:1371-5; PMID:20393462; http://dx.doi.org/10.1038/nature08949
82. Chen VL, Surana NK, Duan J, Kasper DL. Role of murine intestinal interleukin-1 receptor 1-expressing lymphoid tissue inducer-like cells in salmonella infection. PLoS One 2013; 8:e65405; http://dx.doi.org/10.1371/journal.pone.0065405; PMID:23750260
83. - lymphoid cells. EMBO J 2011; 30:2934-47; PMID:21685873; http://dx.doi. org/10.1038/emboj.2011.201
84. Eberl G, Marmon S, Sunshine M-J, Rennert PD, Choi Y, Littman DR. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 2004; 5:64-73; PMID:14691482; http://dx.doi. org/10.1038/ni1022
85. Sawa S, Cherrier M, Lochner M, Satoh-Takayama N, Fehling HJ, Langa F, Di Santo JP, Eberl G. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 2010; 330:665-9; PMID:20929731; http://dx.doi.org/10.1126/ science.1194597
86. Klose CS, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d'Hargues Y, Göppert N, Croxford AL, Waisman A, Tanriver Y, et al. A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells. Nature 2013; 494:261-5; PMID:23334414; http:// dx.doi.org/10.1038/nature11813
87. Eyerich S, Eyerich K, Cavani A, Schmidt-Weber C. IL-17 and IL-22: siblings, not twins. Trends Immunol 2010; 31:354-61; PMID:20691634; http:// dx.doi.org/10.1016/j.it.2010.06.004
88. Huh JR, Leung MWL, Huang P, Ryan DA, Krout MR, Malapaka RRV, Chow J, Manel N, Ciofani M, Kim SV, et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity. Nature 2011; 472:486-90; PMID:21441909; http://dx.doi.org/10.1038/nature09978
89. Gladiator A, Wangler N, Trautwein-Weidner K, Leibund Gut-Landmann S. Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol 2013; 190:521-5; PMID:23255360; http://dx.doi. org/10.4049/jimmunol.1202924
90. Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 2006; 177:4662-9; PMID:16982905
91. Ye P, Garvey PB, Zhang P, Nelson S, Bagby G, Summer WR, Schwarzenberger P, Shellito JE, Kolls JK. Interleukin-17 and lung host defense against infection. Am J Respir Cell Mol Biol 2001; 25:335-40; PMID:11588011; http://dx.doi.org/10.1165/ ajrcmb.25.3.4424
92. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011; 12:383-90; PMID:21502992; http:// dx.doi.org/10.1038/ni.2025
93. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14:282-9; PMID:18264109; http://dx.doi.org/10.1038/nm1720
94. Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008; 118:534-44; PMID:18172556
95. +) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 2011; 34:122-34; PMID:21194981; http://dx.doi. org/10.1016/j.immuni.2010.12.009
96. + cells that provide innate mucosal immune defense. Immunity 2008; 29:958-70; PMID:19084435; http://dx.doi.org/10.1016/j. immuni.2008.11.001
97. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008; 29:947-57; PMID:19100701; http://dx.doi.org/10.1016/j. immuni.2008.11.003
98. Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, Hedl M, Zhang W, O'Connor W Jr., Murphy AJ, et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012; 491:259-63; PMID:23075849; http://dx.doi.org/10.1038/nature11535
99. + innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 2011; 12:320-6; PMID:21336274; http://dx.doi.org/10.1038/ ni.2002
100. Kirchberger S, Royston DJ, Boulard O, Thornton E, Franchini F, Szabady RL, Harrison O, Powrie F. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 2013; 210:917-31; PMID:23589566; http:// dx.doi.org/10.1084/jem.20122308
101. Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J, Shibata N, Grunberg S, Sinha R, Zahm AM, et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012; 336:1321-5; PMID:22674331; http://dx.doi.org/10.1126/ science.1222551
102. Hepworth MR, Monticelli LA, Fung TC, Ziegler CGK, Grunberg S, Sinha R, Mantegazza AR, Ma HL, Crawford A, Angelosanto JM, et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 2013; 498:113-7; PMID:23698371; http://dx.doi.org/10.1038/ nature12240
103. Mebius RE. Organogenesis of lymphoid tissues. Nat Rev Immunol 2003; 3:292-303; PMID:12669020; http://dx.doi.org/10.1038/nri1054
104. Kim D, Mebius RE, MacMicking JD, Jung S, Cupedo T, Castellanos Y, Rho J, Wong BR, Josien R, Kim N, et al. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J Exp Med 2000; 192:1467-78; PMID:11085748; http://dx.doi.org/10.1084/jem.192.10.1467
105. Yoshida H, Naito A, Inoue J, Satoh M, Santee-Cooper SM, Ware CF, Togawa A, Nishikawa S, Nishikawa S. Different cytokines induce surface lymphotoxinalphabeta on IL-7 receptor-α cells that differentially engender lymph nodes and Peyer's patches. Immunity 2002; 17:823-33; PMID:12479827; http://dx.doi. org/10.1016/S1074-7613(02)00479-X
106. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 2002; 17:525-35; PMID:12387745; http://dx.doi.org/10.1016/S1074-7613(02)00423-5
107. Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD, Browning JL, Sedgwick JD, Cyster JG. Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med 1999; 189:403-12; PMID:9892622; http:// dx.doi.org/10.1084/jem.189.2.403
108. Veiga-Fernandes H, Coles MC, Foster KE, Patel A, Williams A, Natarajan D, Barlow A, Pachnis V, Kioussis D. Tyrosine kinase receptor RET is a key regulator of Peyer's patch organogenesis. Nature 2007; 446:547-51; PMID:17322904; http://dx.doi. org/10.1038/nature05597
109. Tsuji M, Suzuki K, Kitamura H, Maruya M, Kinoshita K, Ivanov II, Itoh K, Littman DR, Fagarasan S. Requirement for lymphoid tissueinducer cells in isolated follicle formation and T cellindependent immunoglobulin A generation in the gut. Immunity 2008; 29:261-71; PMID:18656387; http://dx.doi.org/10.1016/j.immuni.2008.05.014
110. -) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity 2003; 18:643-54; PMID:12753741; http://dx.doi.org/10.1016/S1074-7613(03)00110-9
111. Rogers PR, Song J, Gramaglia I, Killeen N, Croft M. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 2001; 15:445-55; PMID:11567634; http://dx.doi.org/10.1016/S1074-7613(01)00191-1
112. Withers DR, Gaspal FM, Mackley EC, Marriott CL, Ross EA, Desanti GE, Roberts NA, White AJ, Flores-Langarica A, McConnell FM, et al. Cutting edge: lymphoid tissue inducer cells maintain memory CD4 T cells within secondary lymphoid tissue. J Immunol 2012; 189:2094-8; PMID:22855716; http://dx.doi. org/10.4049/jimmunol.1201639
113. Gaspal F, Bekiaris V, Kim M-Y, Withers DR, Bobat S, MacLennan ICM, Anderson G, Lane PJ, Cunningham AF. Critical synergy of CD30 and OX40 signals in CD4 T cell homeostasis and Th1 immunity to J Immunol 2008; 180:2824-9; PMID:18292503
114. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II, Littman DR, O'Shea JJ. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009; 206:35-41; PMID:19114665; http://dx.doi.org/10.1084/jem.20072713
115. Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, Johner C, Diefenbach A. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 2009; 10:83-91; PMID:19029903; http://dx.doi.org/10.1038/ni.1684
116. + innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality. Eur J Immunol 2011; 41:1075-85; PMID:21400499; http://dx.doi.org/10.1002/eji.201040878
117. +) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 2010; 33:752-64; PMID:21055975; http://dx.doi.org/10.1016/j. immuni.2010.10.012
118. + natural killer-like cells. Nat Immunol 2009; 10:66-74; PMID:19029905; http://dx.doi. org/10.1038/ni.1668
119. Geremia A, Arancibia-Cárcamo CV, Fleming MP, Rust N, Singh B, Mortensen NJ, Travis SP, Powrie F. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011; 208:1127-33; PMID:21576383; http://dx.doi. org/10.1084/jem.20101712
120. Luci C, Reynders A, Ivanov II, Cognet C, Chiche L, Chasson L, Hardwigsen J, Anguiano E, Banchereau J, Chaussabel D, et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol 2009; 10:75-82; PMID:19029904; http://dx.doi. org/10.1038/ni.1681
121. +) innate lymphocytes. Immunity 2010; 33:736-51; PMID:21093318; http://dx.doi.org/10.1016/j.immuni.2010.10.017
122. Duan J, Chung H, Troy E, Kasper DL. Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing γ/δ T cells. Cell Host Microbe 2010; 7:140-50; PMID:20159619; http:// dx.doi.org/10.1016/j.chom.2010.01.005
123. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM, Kasper DL, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336:489-93; PMID:22442383; http://dx.doi. org/10.1126/science.1219328
124. rd, Onderdonk AB, Kasper DL, Tzianabos AO. Cellular mechanism of intraabdominal abscess formation by J Immunol 1998; 160:5000-6; PMID:9590249
125. Onderdonk AB, Markham RB, Zaleznik DF, Cisneros RL, Kasper DL. Evidence for T cell-dependent immunity to in an intraabdominal abscess model. J Clin Invest 1982; 69:9-16; PMID:6976357; http://dx.doi.org/10.1172/JCI110445
126. Surana NK, Kasper DL. The of bacterial polysaccharides: lessons learned from PSA. Immunol Rev 2012; 245:13-26; PMID:22168411; http://dx.doi. org/10.1111/j.1600-065X.2011.01075.x
127. Avci FY, Kasper DL. How bacterial carbohydrates influence the adaptive immune system. Annu Rev Immunol 2010; 28:107-30; PMID:19968562; http://dx.doi.org/10.1146/ annurev-immunol-030409-101159
128. Avci FY, Li X, Tsuji M, Kasper DL. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med 2011; 17:1602-9; PMID:22101769; http://dx.doi.org/10.1038/nm.2535
129. +) T cell clones from mice after stimulation by two model glycoconjugate vaccines. Nat Protoc 2012; 7:2180-92; PMID:23196974; http://dx.doi.org/10.1038/nprot.2012.138
130. Chen VL, Avci FY, Kasper DL. A maternal vaccine against group B Streptococcus: past, present, and future. Vaccine 2013; 31(Suppl 4):D13-9; http://dx.doi.org/10.1016/j.vaccine.2012.12.080; PMID:23973342
131. Duan J, Avci FY, Kasper DL. Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway. Proc Natl Acad Sci U S A 2008; 105:5183-8; PMID:18381820; http://dx.doi.org/10.1073/ pnas.0800974105
132. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011; 332:974-7; PMID:21512004; http://dx.doi.org/10.1126/ science.1206095
133. An D, Na C, Bielawski J, Hannun YA, Kasper DL. Membrane sphingolipids as essential molecular signals for survival in the intestine. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4666-71; PMID:20855611; http://dx.doi.org/10.1073/pnas.1001501107
134. + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010; 107:12204-9; PMID:20566854; http://dx.doi. org/10.1073/pnas.0909122107
135. Ochoa-Repáraz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. A polysaccharide from the human commensal protects against CNS demyelinating disease. Mucosal Immunol 2010; 3:487-95; PMID:20531465; http:// dx.doi.org/10.1038/mi.2010.29
136. Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. Central nervous system demyelinating disease protection by the human commensal depends on polysaccharide A expression. J Immunol 2010; 185:4101-8; PMID:20817872; http://dx.doi. org/10.4049/jimmunol.1001443
137. + T cells. Inflamm Bowel Dis 2007; 13:1202-11; PMID:17607724; http://dx.doi.org/10.1002/ ibd.20221
138. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4615-22; PMID:20660719; http://dx.doi. org/10.1073/pnas.1000082107
139. Wu H-J, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, Littman DR, Benoist C, Mathis D. Gutresiding segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010; 32:815-27; PMID:20620945; http://dx.doi. org/10.1016/j.immuni.2010.06.001
140. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341:569-73; PMID:23828891; http://dx.doi. org/10.1126/science.1241165
141. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, et al. The Orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003; 278:11312-9; PMID:12496283; http://dx.doi.org/10.1074/jbc.M211609200
142. Nagano Y, Itoh K, Honda K. The induction of Treg cells by gut-indigenous Curr Opin Immunol 2012; 24:392-7; PMID:22673877; http://dx.doi. org/10.1016/j.coi.2012.05.007
143. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine. New York: McGraw-Hill Medical, 2012.
144. Itoh K, Mitsuoka T. Characterization of clostridia isolated from faeces of limited flora mice and their effect on caecal size when associated with germ-free mice. Lab Anim 1985; 19:111-8; PMID:3889493; http://dx.doi.org/10.1258/002367785780942589
145. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263-74; PMID:8402911; http://dx.doi.org/10.1016/0092-8674(93)80068-P
146. Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, Sher A. Triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12-and gamma interferon-dependent mechanism. Infect Immun 1998; 66:5157-66; PMID:9784517
147. + T cells during cure of colitis. J Immunol 2006; 177:5852-60; PMID:17056509
148. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, Centola M, Li X. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis 2009; 15:341-52; PMID:18942757; http://dx.doi. org/10.1002/ibd.20753
149. Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998; 188:1929-39; PMID:9815270; http://dx.doi. org/10.1084/jem.188.10.1929
150. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002; 17:629-38; PMID:12433369; http://dx.doi.org/10.1016/ S1074-7613(02)00453-3
151. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500:232-6; PMID:23842501; http:// dx.doi.org/10.1038/nature12331
152. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011; 145:745-57; PMID:21565393; http://dx.doi. org/10.1016/j.cell.2011.04.022
153. H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008; 453:65-71; PMID:18362915; http://dx.doi.org/10.1038/ nature06880
154. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio C-W, Santacruz N, Peterson DA, Stappenbeck TS, Hsieh CS. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011; 478:250-4; PMID:21937990; http://dx.doi. org/10.1038/nature10434
155. Matzinger P. Friendly and dangerous signals: is the tissue in control? Nat Immunol 2007; 8:11-3; PMID:17179963; http://dx.doi.org/10.1038/ ni0107-11
156. Pédron T, Mulet C, Dauga C, Frangeul L, Chervaux C, Grompone G, Sansonetti PJ. A crypt-specific core microbiota resides in the mouse colon. MBio 2012; 3:3; PMID:22617141; http://dx.doi.org/10.1128/ mBio.00116-12
157. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126:1504-17; PMID:15168363; http://dx.doi. org/10.1053/j.gastro.2004.01.063
158. Mayer L. Evolving paradigms in the pathogenesis of IBD. J Gastroenterol 2010; 45:9-16; PMID:19960355; http://dx.doi.org/10.1007/ s00535-009-0138-3
159. Bamias G, Nyce MR, De La Rue SA, Cominelli F; American College of Physicians; American Physiological Society. New concepts in the pathophysiology of inflammatory bowel disease. Ann Intern Med 2005; 143:895-904; PMID:16365470; http://dx.doi. org/10.7326/0003-4819-143-12-200512200-00007
160. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, et al.; International IBD Genetics Consortium (IIBDGC). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491:119-24; PMID:23128233; http://dx.doi.org/10.1038/ nature11582
161. Khan KJ, Ullman TA, Ford AC, Abreu MT, Abadir A, Marshall JK, Talley NJ, Moayyedi P. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 2011; 106:661-73; PMID:21407187; http://dx.doi. org/10.1038/ajg.2011.72
162. Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 2004; 10:286-99; PMID:15290926; http:// dx.doi.org/10.1097/00054725-200405000-00018
163. Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs 2012; 72:803-23; PMID:22512365; http://dx.doi. org/10.2165/11632710-000000000-00000
164. Martinez J, Huang X, Yang Y. Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog 2010; 6:e1000811; PMID:20300608; http://dx.doi. org/10.1371/journal.ppat.1000811
165. Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M, Moretta L, Moretta A. CpG and doublestranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci U S A 2004; 101:10116-21; PMID:15218108; http://dx.doi.org/10.1073/pnas.0403744101
166. Sonnenberg GF, Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 2012; 37:601-10; PMID:23084357; http://dx.doi.org/10.1016/j. immuni.2012.10.003
167. Ganal SC, Sanos SL, Kallfass C, Oberle K, Johner C, Kirschning C, Lienenklaus S, Weiss S, Staeheli P, Aichele P, et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012; 37:171-86; PMID:22749822; http://dx.doi. org/10.1016/j.immuni.2012.05.020
168. Fink LN, Zeuthen LH, Christensen HR, Morandi B, Frøkiaer H, Ferlazzo G. Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses. Int Immunol 2007; 19:1319-27; PMID:17951600; http://dx.doi.org/10.1093/ intimm/dxm103
169. + cell subsets from Id2-dependent precursors. J Exp Med 2010; 207:273-80; PMID:20142427; http://dx.doi.org/10.1084/ jem.20092029
170. + lymphoid tissue inducer cells. J Immunol 2009; 183:2217-21; PMID:19635901; http://dx.doi. org/10.4049/jimmunol.0802911
171. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, Strominger JL, Yewdell JW, Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001; 409:1055-60; PMID:11234016; http://dx.doi. org/10.1038/35059110
172. Garg A, Barnes PF, Porgador A, Roy S, Wu S, Nanda JS, Griffith DE, Girard WM, Rawal N, Shetty S, et al. Vimentin expressed on-infected human monocytes is involved in binding to the NKp46 receptor. J Immunol 2006; 177:6192-8; PMID:17056548
173. Vankayalapati R, Garg A, Porgador A, Griffith DE, Klucar P, Safi H, Girard WM, Cosman D, Spies T, Barnes PF. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2005; 175:4611-7; PMID:16177106
174. + innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 2013; 38:1223-35; PMID:23791642; http://dx.doi. org/10.1016/j.immuni.2013.05.013
175. Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, Renauld J-C, Vosshenrich CA, Di Santo JP. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against J Immunol 2009; 183:6579-87; PMID:19846871; http://dx.doi. org/10.4049/jimmunol.0901935
176. +) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 2012; 36:276-87; PMID:22306017; http://dx.doi.org/10.1016/j.immuni.2011.12.011
177. Shaw MH, Kamada N, Kim Y-G, Núñez G. Microbiota-induced IL-1β, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J Exp Med 2012; 209:251-8; PMID:22291094; http://dx.doi.org/10.1084/ jem.20111703
178. + immune cells in spleen and mucosa. J Immunol 2010; 185:1177-85; PMID:20566828; http://dx.doi. org/10.4049/jimmunol.1000115
179. Kiss EA, Vonarbourg C, Kopfmann S, Hobeika E, Finke D, Esser C, Diefenbach A. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011; 334:1561-5; PMID:22033518; http://dx.doi.org/10.1126/ science.1214914
180. Rannug U, Rannug A, Sjöberg U, Li H, Westerholm R, Bergman J. Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem Biol 1995; 2:841-5; PMID:8807817; http:// dx.doi.org/10.1016/1074-5521(95)90090-X
181. van de Pavert SA, Mebius RE. New insights into the development of lymphoid tissues. Nat Rev Immunol 2010; 10:664-74; PMID:20706277; http://dx.doi. org/10.1038/nri2832
182. Baptista AP, Olivier BJ, Goverse G, Greuter M, Knippenberg M, Kusser K, Domingues RG, Veiga-Fernandes H, Luster AD, Lugering A, et al. Colonic patch and colonic SILT development are independent and differentially regulated events. Mucosal Immunol 2013; 6:511-21; PMID:22990625; http:// dx.doi.org/10.1038/mi.2012.90
183. + lympho-hemopoietic progenitors develop. J Exp Med 1996; 184:1449-59; PMID:8879216; http://dx.doi.org/10.1084/ jem.184.4.1449